Do cholinesterase inhibitors enhance cognition in schizophrenia?
Current Psychiatry. 2008 March;07(03):96-100
Author and Disclosure Information
Disorder’s heterogeneity may help explain why the answer is unclear.
- when other adjuncts have failed
- as a supplement to other augmentation strategies, such as cognitive-behavioral therapy or family therapy.
- Mohamed S, Paulsen JS, O’Leary D, et al. Generalized cognitive deficits in schizophrenia. Arch Gen Psychiatry 1999;56:749-54.
- Risch SC, Horner MD, McGurk S, et al. Double-blind donepezil-placebo crossover augmentation study of atypical antipsychotics in chronic, stable schizophrenia: a pilot study. Schizophr Res 2007;93:131-5.
- Donepezil • Aricept
- Rivastigmine • Exelon
- Galantamine • Reminyl, Razadyne
- Ziprasidone • Geodon
Dr. Risch receives research support from the National Institute of Mental Health, Abbott Laboratories, GlaxoSmithKline, Bristol-Myers Squibb, and Forest Pharmaceuticals. He is a consultant to and speaker for AstraZeneca and Pfizer Inc.